CO

Envoy Medical IncNASDAQ COCH Stock Report

Last reporting period 30 Jun, 2024

Updated 22 Nov, 2024

Last price

Market cap $B

0.059

Micro

Exchange

XNAS - Nasdaq

COCH Stock Analysis

CO

Uncovered

Envoy Medical Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-66/100

Low score

Market cap $B

0.059

Dividend yield

Shares outstanding

19.6 B

Envoy Medical, Inc. engages in designing, developing and marketing fully implantable medical devices that improve hearing. The company is headquartered in White Bear Lake, Minnesota and currently employs 34 full-time employees. The company went IPO on 2021-03-02. The firm is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

View Section: Eyestock Rating